Product Information

LAMICTAL 150 MG TABLET is a brand product labeled by GlaxoSmithKline LLC, priced at $11.4668 per EA under NDC 00173064360. Its NADAC has been published 657 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the lamotrigine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LAMICTAL 150 MG TABLET

lamotrigine

$11.4668per EA

High Outlier

Strength

150 mg/1

Manufacturer

GlaxoSmithKline LLC

NDC

00173064360

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

LAMOTRIGINE

Approval Type

New Drug (NDA)

FDA Application

NDA020241

On Market Since

1/17/1995

Pharmacological Classes

Anti-epileptic Agent

Decreased Central Nervous System Disorganized Electrical Activity

Dihydrofolate Reductase Inhibitors

Mood Stabilizer

Organic Cation Transporter 2 Inhibitors

Price Statistics

The NADAC for LAMICTAL 150 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 46.7%. The table below summarizes its recorded NADAC range and movement.

Current price	$11.4668 per EA
All-time high	$19.1908 (Oct 11, 2023)
All-time low	$7.8157 (Nov 28, 2013)
52-week high	$11.5015
52-week low	$11.4668
Median price	$13.9642
Average price	$13.8345
Largest weekly change	-41.5% (Dec 27, 2023)
Weeks tracked	657
Tracking since	Nov 28, 2013

Price History

0.0%

-0.0%

-0.1%

-0.3%

-40.2%

-30.3%

All

+46.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the lamotrigine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of LAMICTAL 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LAMICTAL 150 MG TABLET, manufactured by GlaxoSmithKline LLC, is $11.4668 per EA (NDC 00173064360), effective Jun 24, 2026.

How has the price of LAMICTAL 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for LAMICTAL 150 MG TABLET has risen 46.7%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LAMICTAL 150 MG TABLET?

Since Nov 28, 2013, the NADAC for LAMICTAL 150 MG TABLET has ranged from a low of $7.8157 (Nov 28, 2013) to a high of $19.1908 (Oct 11, 2023), with a median of $13.9642 per EA.

Are there cheaper alternatives to LAMICTAL 150 MG TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LAMICTAL 150 MG TABLET, so no direct lower-cost alternative is listed.